TRX-cobimetinib
March 10, 2022 at 07:47 AM EST
Travis – Do you know which company holds the patent for TRX-cobimetinib, a cancer tumor drug that shows promise and may be worth a shot.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.